Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director departure
JANUS HENDERSON GROUP PLC (JHG) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13G/A JANUS HENDERSON GROUP PLC reports a 15.4% stake in MADRIGAL PHARMACEUTICALS, INC.
10/06/2023 SC 13G JANUS HENDERSON GROUP PLC reports a 10.1% stake in SOLENO THERAPEUTICS, INC.
08/18/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/18/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/18/2023 8-K Quarterly results
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/10/2023 SC 13G JANUS HENDERSON GROUP PLC reports a 12.3% stake in AVADEL PHARMACEUTICALS PLC
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/06/2023 4 FOGO GEORGINA (Chief Risk Officer) has filed a Form 4 on JANUS HENDERSON GROUP PLC
Txns: Sold 5,043 shares @ $27.35, valued at $137.9k
07/05/2023 SC 13G JANUS HENDERSON GROUP PLC reports a 5.1% stake in AN2 Therapeutics, Inc.
07/05/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "30 June 2023 JANUS HENDERSON GROUP PLC and BANK OF AMERICA EUROPE DESIGNATED ACTIVITY COMPANY as Coordinator, Bookrunner and Mandated Lead Arranger and as Facility Agent FACILITY AGREEMENT US$200,000,000 REVOLVING CREDIT FACILITY"
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 SC 13G/A JANUS HENDERSON GROUP PLC reports a 0% stake in Bellerophon Therapeutics, Inc.
06/02/2023 3 Seidman Leslie (Director) has filed a Form 3 on JANUS HENDERSON GROUP PLC
06/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Janus Henderson Announces Changes to Board of Directors LONDON – June 2, 2023 – Janus Henderson Group plc today announced that Ed Garden has resigned from the Company’ s Board of Directors, and Josh Frank, a Partner at Trian Fund Management, L.P. , has been appointed as an independent non-executive director in place of Mr. Garden, both effective as of June 9, 2023. Mr. Garden has decided to retire as Trian’ s Chief Investment Officer to focus on managing his personal investments through his family office. He will continue as a Senior Advisor to Trian. Mr. Frank is Co-CIO and a member of Trian’ s Investment Committee. He previously served as Trian’ s Co-Head of Research from 2020 to 2023, and he has been a member of Trian’ s investment team since Trian’ s inception in 2005. Mr. Frank serve..."
05/31/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Janus Henderson Announces Appointment of Leslie F. Seidman to Board of Directors LONDON – May 31, 2023 – Janus Henderson Group plc today announced that Leslie F. Seidman has been appointed to serve as an independent director on the Board of the Company, effective June 1, 2023. Ms. Seidman will also serve as Chair of the Audit Committee and as a member of the Governance and Nominations Committee. Ms. Seidman has over 30 years of experience in the accounting profession, serving as a member of the Financial Accounting Standards Board from 2003 to 2013 and as Chair for the last three years of her term. Previously, Ms. Seidman was the founder and managing member of a financial reporting consulting firm that served global financial institutions, law firms, and accounting firms, served as Vice P..."
05/26/2023 SC 13G/A JANUS HENDERSON GROUP PLC reports a 12.1% stake in Bellerophon Therapeutics, Inc.
05/26/2023 4 Sheehan Anne (Director) has filed a Form 4 on JANUS HENDERSON GROUP PLC
Txns: Granted 4,649 shares @ $25.63, valued at $119.2k
05/26/2023 4 SEYMOUR JACKSON ANGELA (Director) has filed a Form 4 on JANUS HENDERSON GROUP PLC
Txns: Granted 3,067 shares @ $25.63, valued at $78.6k
05/26/2023 4 Quirk Alison A. (Director) has filed a Form 4 on JANUS HENDERSON GROUP PLC
Txns: Granted 4,649 shares @ $25.63, valued at $119.2k
05/26/2023 4 FLOOD EUGENE JR (Director) has filed a Form 4 on JANUS HENDERSON GROUP PLC
Txns: Granted 4,610 shares @ $25.63, valued at $118.2k
05/26/2023 4 DOLAN KEVIN B (Director) has filed a Form 4 on JANUS HENDERSON GROUP PLC
Txns: Granted 3,332 shares @ $25.63, valued at $85.4k
05/26/2023 4 DESAI KALPANA (Director) has filed a Form 4 on JANUS HENDERSON GROUP PLC
Txns: Granted 3,357 shares @ $25.63, valued at $86k
05/26/2023 4 CASSADAY JOHN M (Director) has filed a Form 4 on JANUS HENDERSON GROUP PLC
Txns: Granted 5,793 shares @ $25.63, valued at $148.5k
05/25/2023 SC 13G JANUS HENDERSON GROUP PLC reports a 5.1% stake in Bellerophon Therapeutics, Inc.
05/09/2023 4 Hughes Brennan A. (Chief Accounting Officer) has filed a Form 4 on JANUS HENDERSON GROUP PLC
Txns: Sold 1,874 shares @ $26.686, valued at $50k
05/05/2023 8-K Quarterly results
05/03/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/03/2023 8-K Quarterly results
04/03/2023 144 Form 144 - Report of proposed sale of securities:
03/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/24/2023 8-K Resignation/termination of a director
03/24/2023 ARS Form ARS - Annual Report to Security Holders:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy